Overall rank by patents
#3,462
Across all tracked assignees
USPTO PatentsView assignee record - 107 granted patents across 1 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES).
The verdict
THE holds 107 US patents across 1 technology areas, rank #3,462 of 50,000 tracked assignees.
THE Conard PYLE Company has been granted 107 US utility patents between 2017 and 2025, placing THE Conard PYLE Company at rank #3,462 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent with primary concentration in A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES). As a US Corporation, THE Conard PYLE Company is one of the more focused assignees in the PatentsView dataset. By volume, THE sits between Reckitt Benckiser Finish B.v. (107 patents, rank #3,458) and Atomera Incorporated (106 patents, rank #3,466) - the closest US assignees by grant volume. The composite Innovation Score of 24.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 72 grants, compared with 35 in the 2015–2019 window, a +106% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. THE Conard PYLE Company's 1.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark THE Conard PYLE Company against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Reckitt Benckiser Finish B.V.
107 patents
SACMI COOPERATIVA MECCANICI IMOLA SOCIETA' COOPERATIVA
107 patents
SUNSHINE LAKE PHARMA CO., LTD.
107 patents
THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
107 patents
Vizio, Inc.
107 patents
WMS GAMING, INC.
107 patents
Wah Hung Group Inc
107 patents
THE CONARD PYLE COMPANY
107 patents
ATOMERA INCORPORATED
106 patents
What this shows THE holds 107 patents at rank #3,462, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,462 in granted patent volume.
Other assignees with the most granted patents in THE's primary technology class.
THE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 85% higher than 15% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 8 | 7.5% |
| 2018 | 7 | 6.5% |
| 2019 | 20 | 18.7% |
| 2020 | 13 | 12.1% |
| 2021 | 17 | 15.9% |
| 2022 | 6 | 5.6% |
| 2023 | 5 | 4.7% |
| 2024 | 21 | 19.6% |
| 2025 | 10 | 9.3% |
Top 1 of 1 technology areas
Overall rank by patents
#3,462
Across all tracked assignees
24.6 out of 100
How to use this portfolio
THE's 107 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.